FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082874 [Registered on: 20/03/2025] Trial Registered Prospectively
Last Modified On: 25/02/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of Ayurvedic drug and Allopathy drug to control Pregnancy-Induced Vomiting 
Scientific Title of Study   A Comparative Clinical Study on the Effect of Dhanyaka Kalka with Anupana of Sharkara mixed Tandulodaka and doxylamine in Garbhini Chardi 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nayana Bhagat 
Designation  Associate Professor 
Affiliation  KAHER University 
Address  KAHERs Shri BMK Ayurved Mahavidyalaya Shahapur

Belgaum
KARNATAKA
590003
India 
Phone  8123236686  
Fax    
Email  nayanag.kaher@kleayurworld.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nayana Bhagat 
Designation  Associate Professor 
Affiliation  KAHER University 
Address  KAHERs Shri BMK Ayurved Mahavidyalaya Shahapur

Belgaum
KARNATAKA
590003
India 
Phone  8123236686  
Fax    
Email  nayanag.kaher@kleayurworld.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Nayana Bhagat 
Designation  Associate Professor 
Affiliation  KAHER University 
Address  KAHERs Shri BMK Ayurved Mahavidyalaya Shahapur

Belgaum
KARNATAKA
590003
India 
Phone  8123236686  
Fax    
Email  nayanag.kaher@kleayurworld.edu.in  
 
Source of Monetary or Material Support  
KAHER University, Neharu Nagar Belagavi, Karnataka, India Pin: 590001 
 
Primary Sponsor  
Name  KAHER University 
Address  Neharu Nagar Belagavi Karnataka India Pin: 590001 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
KAHER  Shri BMK AMV Belagavi Karnataka 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nayana Bhagat  KLE Ayurveda Hospital  PTSR Department Prasooti Tantra, Room No. 23, Shahapur Belagavi
Belgaum
KARNATAKA 
8123236686

nayanag.kaher@kleayurworld.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee for research on human subjects  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:O00-O9A||Pregnancy, childbirth and the puerperium. Ayurveda Condition: GARBINIROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Dhanyak Kalka, Reference: Prasooti Tantra evam Stree roga part 1 Chapter 06 Garbhin vyadhiyan evam unki chikitsa page no, 249, sloka 11, Route: Oral, Dosage Form: Kalka/ Paste , Dose: 12(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: Tandulodaka), Additional Information: Tandulodaka 80ml BID
2Comparator Arm (Non Ayurveda)-DoxylamineOrally 10mg BID after food for 14 days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  First-trimester 
 
ExclusionCriteria 
Details  Subjects in whom Chardi is seen in second and third trimester of Pregnancy.
Subjects with Hyperemesis gravidarum.
Subjects with twin pregnancy.
Subjects with vesicular mole.
Vomiting caused due to other systemic disorders like peptic ulcer, appendicitis etc.
Subjects suffering from severe infections.
Subjects suffering from chronic systemic diseases 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Centralized 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Control vomiting  2 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   16/03/2037 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

 

Garbhini Chardi, commonly known as vomiting during pregnancy, poses significant challenges to maternal health and well-being. This condition, characterized by frequent and persistent vomiting episodes, can lead to dehydration, malnutrition, electrolyte imbalances, and overall diminished quality of life for pregnant women. While various treatments exist, including antiemetic medications, dietary modifications, and intravenous fluids, they often provide incomplete relief and may carry risks for both maternal and fetal health
Ayurveda, offers alternative approaches to managing Garbhini Chardi. One such formulation is Dhanyaka Kalka with Anupana of Sharkara mixed Tandulodaka ( Yogaratnakar streerogachikitsa). Dhanyaka, also known as coriander, possesses digestive, carminative, and antiemetic properties in Ayurveda.

.Traditional Ayurvedic texts emphasize the importance of administering treatments that are easily palatable and preferred by the patient, aligning with the holistic approach to care. Therefore, investigating the efficacy of Dhanyaka Kalka with Anupana of Sharkara mixed Tandulodaka  in Garbhini Chardi holds promise for providing a safe, effective, and culturally sensitive treatment option for pregnant women.

        By conducting a comparative clinical study, we aim to scientifically evaluate the effectiveness of this Ayurvedic formulation in reducing vomiting frequency and severity, improving maternal quality of life, and ensuring fetal well-being. This research seeks to bridge the gap between traditional Ayurvedic knowledge and modern evidence-based medicine, paving the way for integrative approaches to prenatal care and enhancing outcomes for pregnant women worldwide.
 
Close